User safety of topically administered products

  • Email
  • Help
Current version

Draft guideline

Currently under revision - see below

Reference numberEMA/CVMP/SWP/721059/2014
Published27/06/2016
Keywordsantimicrobial, summary of product characteristics, SPC, veterinary medicinal products, responsible use, resistance, susceptibility testing, breakpoints
DescriptionThe guideline, which was developed to encourage optimal use and to minimise selection of antimicrobial resistance (AMR), was revised in order to improve consistency of the summary of product characteristics (SPCs) for antimicrobial products in the EU Member States.


Document history

First version
In progress

Adopted guideline

 

Overview of comments


Draft guideline


 

Concept paper

Published: 07/05/2018
Effective from: 01/11/2018
 

Published: 07/05/2018

 

Published: 27/06/2016
Deadline for comments: 31/12/2016


Published: 14/04/2005


Related content


How helpful is this page?

Average rating:

 Based on 15 ratings

Add your rating:

See all ratings
3 ratings
3 ratings
3 ratings
3 ratings
3 ratings
    

Tell us more